Desazadesmethyldesferrithiocin analogues as orally effective iron chelators

Journal of Medicinal Chemistry

Volumn 42, Issue 1, 1999, Pages 95-108

  Bergeron, Raymond J ^a   Wiegand, Jan ^a   Weimar, William R ^a   Vinson, J R Timothy ^a   Bussenius, Jörg ^a   Yao, Guo Wei ^a   McManis, James S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIHYDROXYPHENYL) DELTA 2 THIAZOLINE 4 CARBOXYLIC ACID; DEFERRIFERRITHIOCIN; DEFERRIFERRITHIOCIN DERIVATIVE; DESAZANORDESFERRITHIOCIN; IRON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; GASTROINTESTINAL TOXICITY; IRON CHELATION; IRON OVERLOAD; KIDNEY FAILURE; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0033552882     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980340j     Document Type: Article

References (51)

1. Raymond, K. N.; Carrano, C. J. Coordination Chemistry and Microbial Iron Transport. Acc. Chem. Res. 1979, 12, 183-190.
2. Bergeron, R. J. Iron: A Controlling Nutrient in Proliferative Processes. Trends Biochem. Sci. 1986, 11, 133-136.
3. Finch, C. A.; Deubelbeiss, K.; Cook, J. D.; Eschbach, J. W.; Harker, L. A.; Funk, D. D.; Marsaglia, G.; Hillman, R. S.; Slichter, S.; Adamson, J. W.; Ganzoni, A.; Giblett, E. R. Ferrokinetics in Man. Medicine (Baltimore) 1970, 49, 17-53.
4. Finch, C. A.; Huebers, H. A. Perspectives in Iron Metabolism. N. Engl. J. Med. 1982, 306, 1520-1528.
5. Finch, C. A.; Huebers, H. A. Iron Metabolism. Clin. Physiol. Biochem. 1986, 4, 5-10.
6. Hallberg, L. Bioavailability of Dietary Iron in Man. Annu. Rev. Nutr. 1981, 1, 123-147.
7. O'Connell, M. J.; Ward, R. J.; Baum, H.; Peters, T. J. The Role of Iron in Ferritin- and Haemosiderin-Mediated Lipid Peroxidation in Liposomes. Biochem. J. 1985, 229, 135-139.
8. Seligman, P. A.; Klausner, R. D.; Huebers, H. A. Molecular Mechanisms of Iron Metabolism. In The Molecular Basis of Blood Diseases; Stamatoyannopoulos, G., Nienhuis, A. W., Leder, P., and Majeris, P. W., Eds.; W. B. Saunders: Philadelphia, 1987; p 219.
9. Thomas, C. E.; Morehouse, L. A.; Aust, S. D. Ferritin and Superoxide-Dependent Lipid Peroxidation. J. Biol. Chem. 1985, 260, 3275-3280.
10. Bickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer, E.; Wettstein, A. Metabolic Products of Actinomycetes. XXVII. Constitutional Formula of Ferrioxamine B. Helv. Chim. Acta 1960, 43, 2129-2138.
11. Lee, P.; Mohammed, N.; Marshall, L.; Abeysinghe, R. D.; Hider, R. C.; Porter, J. B.; Singh, S. Intravenous Infusion Pharmacokinetics of Desferrioxamine in Thalassaemic Patients. Drug Metab. Dispos. 1993, 21, 640-644.
12. Pippard, M. J.; Callender, S. T.; Finch, C. A. Ferrioxamine Excretion in Iron-Loaded Man. Blood 1982, 60, 288-294.
13. Pippard, M. J. Desferrioxamine-Induced Iron Excretion in Humans. Bailleres Clin. Haematol. 1989, 2, 323-343.
14. Bergeron, R. J. Synthesis and Solution Structures of Microbial Siderophores. Chem. Rev. 1984, 84, 587-602.
15. Raymond, K. N.; Müller, G.; Matzanke, B. F. Complexation of Iron by Siderophores. Top. Curr. Chem. 1984, 123, 49-102.
16. Matzanke, B. F.; Müller-Matzanke, G.; Raymond, K. N. Physical Bioorganic Chemistry, VCH: Deerfield Beach, 1989.
17. Naegeli, H.-U.; Zähner, H. Metabolites of Microorganisms. Part 193. Ferrithiocin. Helv. Chim. Acta 1980, 63, 1400-1406.
18. Hahn, F. E.; McMurry, T. J.; Hugi, A.; Raymond, K. N. Coordination Chemistry of Microbial Iron Transport. 42. Structural and Spectroscopic Characterization of Diastereomeric Cr(III) and Co(III) Complexes of Desferrithiocin. J. Am. Chem. Soc. 1990, 112, 1854-1860.
19. Anderegg, G.; Räber, M. Metal Complex Formation of a New Siderophore Desferrithiocin and of Three Related Ligands. J. Chem. Soc., Chem. Commun. 1990, 1194-1196.
20. Bergeron, R. J.; Wiegand, J.; Dionis, J. B.; Egli-Karmakka, M.; Frei, J.; Huxley-Tencer, A.; Peter, H. H. Evaluation of Desferrithiocin and its Synthetic Analogues as Orally Effective Iron Chelators. J. Med. Chem. 1991, 34, 2072-2078.
21. Bergeron, R. J.; Liu, C. Z.; McManis, J. S.; Xia, M. X. B.; Algee, S. E.; Wiegand, J. The Desferrithiocin Pharmacophore. J. Med. Chem. 1994, 37, 1411-1417.
22. Bergeron, R. J.; Streiff, R. R.; Creary, E. A.; Daniels, R. D., Jr.; King, W.; Luchetta, G.; Wiegand, J.; Moerker, T.; Peter, H. H. A Comparative Study of the Iron-Clearing Properties of Desferrithiocin Analogues with Desferrioxamine B in a Cebus Monkey Model. Blood 1993, 81, 2166-2173.
23. Bergeron, R. J.; Wiegand, J.; Wollenweber, M.; McManis, J. S.; Algee, S. E.; Ratliff-Thompson, K. Synthesis and Biological Evaluation of Naphthyldesferrithiocin Iron Chelators. J. Med. Chem. 1996, 39, 1575-1581.
24. Bergeron, R. J.; McManis, J. S.; Dionis, J. B.; Garlich, J. R. An Efficient Total Synthesis of Agrobactin and its Gallium (III) Chelate. J. Org. Chem. 1985, 50, 2780-2782.
25. Karmakar, S. N.; Kelkar, S. L.; Wadia, M. S. A Simple Unusual One-Step Conversion of Aromatic Aldehydes into Nitriles. Synthesis 1985, 510-512.
26. North, M.; Pattenden, G. Synthetic Studies Towards Cyclic Peptides. Concise Synthesis of Thiazoline and Thiazole Containing Amino Acids. Tetrahedron 1990, 46, 8267-8290.
27. Yoshinaga, J.; Shogaki, T.; Kakita, T.; Ozeki, H.; Sugimoto, N.; Kato, Y. Preparation and Testing of Tetrazolylcarbamoylthiazoles as Allergy Inhibitors. EP 262873, April 6, 1988; Chem. Abstr. 1988, 109, 54782u.
28. Bergeron, R. J.; Kline, S. J. Short Synthesis of Parabactin. J. Am. Chem. Soc. 1982, 104, 4489-4492.
29. Katsuyasu, M.; Osawa, Y.; Kudome, M. Anticholesteremics Containing Phenylimidazoline Derivatives. JP 61,115,022, June 2, 1986; Chem. Abstr. 1986, 105, 197176c.
30. Shriner, R. L.; Neumann, F. W. The Chemistry of the Amidines. Chem. Rev. 1944, 35, 351-425.
31. Kato, E.; Yamamoto, K.; Kawashima, Y.; Watanabe, T.; Oya, M.; Iso, T.; Iwao, J.-I. Synthesis and Antihypertensive Activity of 5-(2-Hydroxyphenyl)-1-(3-mercaptopropionyl)-2-pyrrolidinecarboxylic Acids. Chem. Pharm. Bull. 1985, 33, 4836-4846.
32. Schwartz, M. A.; Zoda, M.; Vishnuvajjala, B.; Mami, I. A Convenient Synthesis of o- and p-Hydroxy Substituted Phenylacetonitriles and Phenethylamines. J. Org. Chem. 1976, 41, 2502-2503.
33. Wilk, S.; Thurston, L. S. Inhibition of Angiotensin III Formation by Thiol Derivatives of Acidic Amino Acids. Neuropeptides 1990, 16, 163-168.
34. Hamprecht, D.; Josten, J.; Steglich, W. Optically Active 2H-Azepines: Synthesis and Rearrangement into their 3H-Isomers. Tetrahedron 1996, 52, 10883-10902.
35. 4. Chem. Lett. 1979, 981-982.
36. Chauvel, E. N.; Coric, P.; Llorens-Cortes, C.; Wilk, S.; Roques, B. P.; Fournie-Zaluski, M.-C. Investigation of the Active Site of Aminopeptidase A Using a Series of New Thiol-Containing Inhibitors. J. Med. Chem. 1994, 37, 1339-1346.
37. Ramsamy, K.; Olsen, R. K.; Emery, T. Synthesis of N-t-Boc-L-α-aminoadipic Acid 1-tert-Butyl 6-Ethyl Ester from L-Aspartic Acid: A New Route to L-α-Aminoadipic Acid. Synthesis 1982, 42-43.
38. Vorbrüggen, H.; Krolikiewicz, K. Trimethylsilanol as Leaving Group; III. A Simple One-Step Conversion of Aromatic Heterocyclic N-Oxides to α-Cyano Aromatic N-Heterocycles. Synthesis 1983, 316-319.
39. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Luchetta, G.; Creary, E. A.; Peter, H. H. A Comparison of the Iron-Clearing Properties of 1,2-Dimethyl-3-Hydroxypyrid-4-One, 1,2-Diethyl-3-Hydroxypyrid-4-One, and Deferoxamine. Blood 1992, 79, 1882-1890.
40. Wolfe, L. C.; Nicolosi, R. J.; Renaud, M. M.; Finger, J.; Hegsted, M.; Peter, H.; Nathan, D. G. A Non-Human Primate Model for the Study of Oral Iron Chelators. Br. J. Haematol. 1989, 72, 456-461.
41. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Vinson, J. R. T.; Luchetta, G.; Evans, K. M.; Peter, H.; Jenny, H.-B. A Comparative Evaluation of Iron Clearance Models. Ann. N. Y. Acad. Sci. 1990, 612, 378-393.
42. Bergeron, R. J.; Wiegand, J.; Brittenham, G. M. HBED: A Potential Alternative to Deferoxamine for Iron-Chelating Therapy. Blood 1998, 91, 1446-1452.
43. Gomori, G. Preparation of Buffers for Use in Enzyme Studies. Methods Enzymol. 1955, 1, 138-146.
44. 2-thiazoline-4-carbonyl)-L-lysines] with Antiviral Activity. Ind. J. Chem. 1977, 15B, 255-257.
45. Marcus, E. About Nitrogen Containing Derivatives of Some Dihydroxybenzaldehydes. Ber. Dtsch. Chem. Ges. 1891, 24, 3650-3657.
46. Wollenweber, E.; Mann, K.; Iinuma, M.; Tanaka, T.; Mizumo, M. 8,2′-Dihydroxyflavone from Primula pulverulenta. Phytochemistry 1988, 27, 1483-1486.
47. Cavina, G.; Cingolani, E. Several Hydroxyformylbenzoic Acids. Rend. Ist. Super. Sanita 1955, 18, 750-765.
48. Crow, W. D.; Engkaninan-Low, U.; Pang, Y. T. Synthetic Applications of Intramolecular Insertion in Arylcarbenes. VII. Aryl-Substituted Benzocycloalkenylidenes. Aust. J. Chem. 1984, 37, 1915-1924.
49. Breiding-Mack, S.; Zeeck, A. Secondary Metabolites by Chemical Screening. I. Calcium 3-Hydroxyquinoline-2-Carboxylate from a Streptomyces. J. Antibiot. 1987, 40, 953-960.
50. Wood, J. K.; Milner, P. F.; Pathak, U. N. The Metabolism of Iron-Dextran Given as a Total-Dose Infusion to Iron Deficient Jamaican Subjects. Br. J. Haematol. 1968, 14, 119-129.
51. Sangster, J. In Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry; Wiley Series in Solution Chemistry; Fogg, P. G. T., Ed.; John Wiley and Sons: West Sussex, England, 1997.